Summary
Human psoriatic epidermis and scales were demostrated to contain two antigenically separate cysteine proteinase inhibitors, one acidic with an isoelectric point of 4.7–5.0 (ACPI) and one neutral with an isoelectric point of 6.0–6.5 (NCPI), while normal epidermis contains only ACPI. The total papain (cysteine proteinase) inhibiting activity of the psoriatic epidermis as calculated per mg protein was higher than that in normal epidermis. Both ACPI and NCPI were localized immunocytochemically, mainly in the highest spinous cell layers with less activity in the parakeratotic cells and lower layers of spinous cells. Basal cells were essentially negative.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Barrett AJ, Starkey PM (1973) The interaction of α2-macroglobulin with proteinases. Characteristics and specificity of the reaction and a hypothesis concerning its molecular mechanism. Biochem J 133:709–727
Collen D, Wiman B, Verstraete M (eds) (1979) Physiological inhibitors of blood coagulation and fibrinolysis. Elsevier/North Holland, Amsterdam
Fräki JE (1977) Human skin proteases. Effect of separated proteases on vascular permeability and leukocyte emigration in skin. Acta Derm Venereol (Stockh) 57:393–398
Fräki JE, Hopsu-Havu VK (1976a) Human skin proteases: Fractionation of psoriasis scale proteinases and separation of a plasminogen activator and histone hydrolysing protease. Arch Dermatol Res 256:113–126
Fräki JE, Hopsu-Havu VK (1976b) Plasminogen activator and histone hydrolysing proteases in psoriatic scales—possible role in increased cell division. Ann Clin Res 8:335–339
Hatcher VB, Lazarus GS, Levine N, Burk PG, Yost FJ Jr (1977) Characterization of a chemotactic and cytotoxic proteinase from human skin. Biochim Biophys Acta 483:160–171
Hopsu-Havu VK, Joronen I, Järvinen M, Rinne A (1982a) A new cysteine proteinase inhibitor in human serum. Eur Rev Med Pharmacol Sci 4:389–394
Hopsu-Havu VK, Joronen I, Järvinen M, Rinne A (1982b) Detection of acid cysteine-proteinase inhibitor in human tissues and serum with RIA. Eur Rev Med Pharmacol Sci 5:1–4
Järvinen M (1976) Purification and properties of two protease inhibitors from rat skin inhibiting papain and other SH-proteases. Acta Chem Scand [B] 30:933–940
Järvinen M (1978) Purnication and some characteristics of the human epidermal SH-protease inhibitor. J Invest Dermatol 71:114–118
Järvinen M (1979) Purification and some characteristics of two human serum proteins inhibiting papain and other thiol proteinases. FEBS Lett 108:461–464
Järvinen M, Hopsu-Havu VK (1975) α-N-Benzoylarginine-2-naphthylamide hydrolase (Cathepsin B1?) from rat skin. II. Purification of the enzyme and demonstration of two inhibitors in the skin. Acta Chem Scand [B] 29:772–780
Järvinen M, Rinne A (1982) Huinan spleen cysteine proteinase inhibitor. Purification and fractionation into isoelectric variants and some properties of the variants. Biochim Biophys Acta 708: 210–217
Kopitar M, Brzin J, Zvonar T, Loćnicar P, Kregar I, Turk V (1978) Inhibition studies of an intracellular inhibitor on thiol proteinases. FEBS Lett 91:355–359
Lazarus GS, Yost FJ, Thomas CA (1977) Polymorphonuclear leukocytes: Possible mechanism of accumulation in psoriasis. Science 198:1062–1163
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265–275
Mancini G, Carboanara AO, Heremans JF (1965) Immunochemical quantitation of antigens by single radial immunodiffusion. Int J Immunochem 2:235–254
Ohtani O, Fukuyama K, Epstein WL (1982) Biochemical properties of thiolproteinase inhibitor purified from psoriatic scales. J Invest Dermatol 78:280–284
Rinne A, Järvinen M, Räsänen O (1978) A protein renimiscent of the epidermal SH-protease inhibitor occurs in squamous epithelia of man and rat. Acta Histochem 63:183–192
Rinne A, Räsänen O, Järvinen M, Vanhatalo E (1979) Localization of the rat epidermal SH-protease inhibitor in the proventricular squamosus epithelium using the peroxidase-antiperoxidase (PAP) method. Acta Histochem 64:51–54
Ryley HC (1979) Isolation and partial characterization of a thiolproteinase inhibitor from human plasma. Biochem Biophys Res Commun 89:871–878
Sasaki M, Taniguchi K, Minakata K (1981) Multimolecular forms of thiol proteinase inhibitor in human plasma. J Biochem 89:169–177
Sternberger LS, Hardy PH, Cuculis JJ, Meyer HC (1970) The unlabelled antibody enzyme method in immunohistochemistry: Preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in the identification of spirochetes. J Histochem Cytochem 18:315–333
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hopsu-Havu, V.K., Joronen, I.A., Järvinen, M. et al. Cysteine proteinase inhibitors in psoriatic epidermis. Arch Dermatol Res 275, 305–309 (1983). https://doi.org/10.1007/BF00417202
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00417202